Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M629Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M18.2EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)19.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book6.910-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.3PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M5,296,503ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BBH

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BBH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BBH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Element, MartynDirector 2016-08-08Buy10,000$0.1579026.67view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell200$12.1880.91view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell1,800$12.1880.91view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell2,000$12.11880.1view
Ghuldu, RishiSenior Officer 2016-08-08Sell149$23.45406.14view
Louis, PeterSenior Officer 2016-08-08Sell5,000$87.8635.09view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy5,000$1.76881.76view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy4,700$1.657093.33view
Kovacevic, John GianniDirector, Senior Officer 2016-08-08Buy200,000$0.08148262.5view
Espaillat Lamarche, Julio ErneSenior Officer 2016-08-08Sell190,000$0.619681.67view

Quarterly/Annual Reports about BBH:

    News about BBH:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Pfizer’s Medivation Acquisition: What You Need to Know Aug 23 2016
    Ozanimod May Prove to Be a Strong Growth Driver for Celgene Aug 18 2016
    These Concerns Affected Gilead’s Change in Full-Year Guidance Aug 02 2016
    Vertex’s Orkambi to Treat Cystic Fibrosis Drives Company’s Growth Aug 01 2016
    BioMarin: Why So Many ‘Buy’ Recommendations? Jul 31 2016
    Why Did Alnylam Pharmaceuticals’s Valuation Multiples Drop in 2016? Jul 08 2016
    Understanding the Valuation Catalysts for BioMarin in 4Q16 Jul 06 2016
    Hunting for value Jul 01 2016
    Deutsche Balaton AG :BBH-DE: Earnings Analysis: For the six months ended December 31, 2015 : June... Jun 29 2016
    Which Biotechnology Companies Could Benefit from Brexit? Jun 28 2016
    As Cost Panel Gets Delayed, Buy These 3 Biotech ETFs Jun 23 2016
    Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead May 17 2016
    What Lies Ahead for Biotech ETFs? May 13 2016
    Will the Current Pipeline Help Medivation Go beyond Xtandi? May 12 2016
    The Story behind Medivation’s Rising Collaboration Revenue May 11 2016
    A Promising Uptake for Vertex’s Orkambi May 04 2016
    Biotech ETFs Sink on Mixed Q1 Results May 02 2016
    2 Dirt-Cheap Big Pharma Stocks Poised to Beat Biotech's Bad Rap May 02 2016
    Why Is Medivation at a Premium on an EV-to-EBITDA Basis? Apr 14 2016
    A Rare Opportunity With A Biotechnology ETF Mar 17 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)